RT Journal Article
SR Electronic
T1 606 IMpower110: Tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first-line atezolizumab or chemotherapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A690
OP A690
DO 10.1136/jitc-2023-SITC2023.0606
VO 11
IS Suppl 1
A1 Srivastava, Minu K
A1 Gayevskiy, Velimir
A1 Ma, Vy
A1 Estay, Ivette
A1 Rodas, Miguel Lopez de
A1 Rajendran, Barani Kumar
A1 Hoang, Tien
A1 Ballinger, Marcus
A1 Amin, Reena
A1 Herbst, Roy S
A1 Marinis, Filippo de
A1 Giaccone, Giuseppe
A1 Jassem, Jacek
A1 Spigel, David R
A1 Schalper, Kurt
A1 Koeppen, Hartmut
A1 Shames, David S
A1 Johnston, Robert
A1 Giltnane, Jennifer M
A1 Nabet, Barzin Y
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A690.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.